Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00642_DB01009_nanopub.RAm9cnnvHG4SNlcIxtetHvGj8j6MQ79l0oOnMxwvyMqtY#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00642_DB01009 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00642_DB01009 label "DDI between Pemetrexed and Ketoprofen - The NSAID, ketoprofen, may increase increase the serum concentration of pemetrexed by decreasing its renal clearance. Patients with mild to moderate renal insufficiency (CrCl 45-79 ml/min) should avoid use of ketoprofen within 2 days of a pemetrexed dose. Patients with better renal function do not appear to be at risk. Monitor for toxicity in all patients during concomitant therapy. [drugbank_resource:DB00642_DB01009]" assertion.
- drugbank_resource:DB00642_DB01009 identifier "drugbank_resource:DB00642_DB01009" assertion.
- drugbank_resource:DB00642_DB01009 title "DDI between Pemetrexed and Ketoprofen - The NSAID, ketoprofen, may increase increase the serum concentration of pemetrexed by decreasing its renal clearance. Patients with mild to moderate renal insufficiency (CrCl 45-79 ml/min) should avoid use of ketoprofen within 2 days of a pemetrexed dose. Patients with better renal function do not appear to be at risk. Monitor for toxicity in all patients during concomitant therapy." assertion.
- drugbank:DB00642 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00642_DB01009 assertion.
- drugbank:DB01009 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00642_DB01009 assertion.